MiddleBrook Pharmaceuticals launches Web site for Moxatag

WESTLAKE, Texas The maker of the first once-daily formulation of the antibiotic amoxicillin has launched a Web site to accompany the product.

MiddleBrook Pharmaceuticals, which launched Moxatag in March, announced Friday the launch of www.moxatag.com, calling it a comprehensive online resource for information about treating pharyngitis and tonsillitis with Moxatag. The site includes information about the causes and symptoms of the diseases, while a video shows how MiddleBrook’s proprietary Pulsys drug-delivery technology prolongs the release and absorption of the drug.

“Moxatag is a unique product with no AB-rated generic, and Moxatag has valuable benefits for patients and prescribers,” MiddleBrook president and CEO John Thievon said.